|

TILs（Tumor Infiltrating Lymphocytes） Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • University Hospital, Basel, Switzerland1

Indications

  • Lung Cancer (NSCLC)1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.